New Rhein Healthcare Investors is a private equity firm focused on life sciences, investing in later-stage, de-risked assets with proven clinical safety and efficacy. The firm combines deal-making expertise with deep operating experience to actively manage value creation across a small portfolio of portfolio companies. Its trans-Atlantic platform coordinates corporate and portfolio offices with strategic partnerships, aiming for product development execution and meaningful exits that benefit patients and investors. Headquarters and activity span the United States and Europe, including Philadelphia, PA, and Mechelen, Belgium.
No recent news for this company.